Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
This article was originally published in The Tan Sheet
Executive Summary
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction
You may also be interested in...
Emord Extends Effort To Liberalize QHCs With Selenium, Antioxidant Petitions
Attorney Jonathan Emord continues his effort to force FDA to allow more expansive qualified health claims for nutritional supplements with two petitions relating to the capability of selenium and antioxidant vitamins to reduce the risk of site-specific cancers
Emord Extends Effort To Liberalize QHCs With Selenium, Antioxidant Petitions
Attorney Jonathan Emord continues his effort to force FDA to allow more expansive qualified health claims for nutritional supplements with two petitions relating to the capability of selenium and antioxidant vitamins to reduce the risk of site-specific cancers
Emord Extends Effort To Liberalize QHCs With Selenium, Antioxidant Petitions
Attorney Jonathan Emord continues his effort to force FDA to allow more expansive qualified health claims for nutritional supplements with two petitions relating to the capability of selenium and antioxidant vitamins to reduce the risk of site-specific cancers